JF
Insider
Jeffrey S Farrow
See RemarksJeffrey S Farrow (See Remarks) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Tarsus Pharmaceuticals, Inc. (TARS). The largest single filing was $877K of TARS (14,396 sh × $60.95, as filed), executed Jun 16.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.3M
shares × price, as filed
Last traded
Jun 16
Filed Jun 17
Median ADV $68.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
TARSRecent filings
TARSSALE
Tarsus Pharmaceuticals, Inc.
View filing →
$877K14,396 sh × $60.95
Exec Jun 16
Filed Jun 17 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $440K
6,430 sh across 3 lots
Exec Mar 17
Filed Mar 19 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $550K
13,608 sh × $40.42
Exec Jun 17 2025
Filed Jun 18 2025 · 5:30 PM ET